AERIE PHARMACEUTICALS INC Annual Operating Income (Loss) in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2021.
  • Aerie Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2022 was -$26.7M, a 17.6% increase year-over-year.
  • Aerie Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was -$26.7M, a 80% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$46.4M, a 70.2% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$156M, a 17% increase from 2019.
  • Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2019 was -$187M, a 10.6% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$46.4M +$109M +70.2% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-25
2020 -$156M +$31.8M +17% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 -$187M +$22.3M +10.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$210M -$64M -44% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$146M -$48.8M -50.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$96.9M -$21.8M -29% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$75.1M -$25.1M -50.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$50M -$27.8M -125% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 -$22.2M -$7.88M -55.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-02
2012 -$14.3M -$77K -0.54% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$14.2M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.